Tandem Diabetes Care
Manufacturer of automated insulin delivery systems for diabetes management.
Company facts
- Founded
- 2006
- Employees
- 2,650
- Headquarters
- United States
- CEO
- John Sheridan
- Type
- Public
- Listed
- NASDAQ: TNDM
- Subsidiaries
- Sigi
About
At Tandem Diabetes Care, we are revolutionizing diabetes management through groundbreaking technology and a relentless focus on the user experience. Our journey began in 2006, and by 2008, Tandem Diabetes Care, Inc. was formed with a clear mission: to develop innovative solutions that simplify and improve the lives of people with diabetes. We believe that managing diabetes shouldn't mean compromising on lifestyle. That's why we pioneered the first touchscreen insulin pump, the t:slim Insulin Pump, launched in 2012, setting a new standard for ease of use and modern design in medical devices. This user-centric philosophy drives our continuous innovation, leading to advancements like the t:slim X2 insulin pump, which is capable of remote software updates, ensuring our users always have access to the latest features without needing to change their hardware frequently. Our commitment to technological advancement is further exemplified by our development of sophisticated algorithms like Basal-IQ and Control-IQ technology. Control-IQ technology, an advanced hybrid closed-loop system, automatically adjusts insulin delivery based on continuous glucose monitoring (CGM) data, predicting and helping to prevent both high and low glucose levels. This technology represents a significant step towards a fully automated insulin delivery system, reducing the daily burden on individuals with diabetes and empowering them to live fuller lives. We actively collaborate with other leaders in the diabetes space, such as Dexcom and Abbott, to integrate their cutting-edge CGM systems with our pumps, providing a seamless and comprehensive diabetes management experience. Through these partnerships and our own research and development, including collaborations with institutions like the University of Virginia Center for Diabetes Technology, we are constantly pushing the boundaries of what's possible in insulin therapy and automated insulin delivery. Our focus remains steadfast on creating a positively different experience for the diabetes community, driven by innovation and a deep understanding of their needs.